Harpoon Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
SOUTH SAN FRANCISCO, Calif., Aug. 02, 2022 Harpoon Therapeutics, Inc. , a clinical-stage immunotherapy company developing novel T cell engagers, today announced that management will participate.
Harpoon Presents Interim Data from Ongoing Dose Escalation Portion of T Cell Engager HPN328 Clinical Trial at 2022 ASCO Annual Meeting forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Harpoon Therapeutics (NASDAQ:HARP – Get Rating) had its target price lowered by HC Wainwright from $31.00 to $18.00 in a research report released on Monday morning, The Fly reports. The brokerage currently has a buy rating on the stock. A number of other research firms also recently weighed in on HARP. SVB Leerink cut their […]